Belite Bio Moves Closer to First-Ever Stargardt Tr...
Category : Clinical Trial Update 24 April 2026Stargardt disease type 1 is not just rare. It is relentless. Typically begins in adolescence...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Roche’s Fenebrutinib Raises the Bar in Multiple Sc...
Category : Clinical Trial Update 24 April 2026For years, multiple sclerosis (MS) treatment has followed a trade-off: Oral drugs → conve...
Spinogenix Advances First-in-Class Fragile X Thera...
Category : Clinical Trial Update 24 April 2026For a condition with no approved treatments, even incremental progress matters. This is not incremen...
Ultomiris Shows Promise in IgA Nephropathy: What t...
Category : Clinical Trial Update 23 April 2026The race to slow kidney disease progression just got more interesting. Ultomiris has delivered posit...
CRENESSITY Delivers 2-Year Data in CAH: Less Stero...
Category : Clinical Trial Update 23 April 2026For decades, treating congenital adrenal hyperplasia meant a trade-off: control hormones, but accept...
Latest Newsletter Post
-
Spinogenix Advances First-in-Class..
24 April 2026
-
Roche’s Fenebrutinib Raises the Bar..
24 April 2026
-
Belite Bio Moves Closer to First-Ev..
24 April 2026
-
CRENESSITY Delivers 2-Year Data in..
23 April 2026
-
Ultomiris Shows Promise in IgA Neph..
23 April 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com